Nicolette Sherman
Président chez Deirdres House
Fortune : 412 868 $ au 31/05/2024
Profil
Nicolette D.
Sherman's current job is Chairman at Deirdres House.
Ms. Sherman's former jobs include being the VP-North America Human Resources Operations at Sanofi Corp.
from 2008 to 2020, the Chief Human Resources Officer at Oyster Point Pharma, Inc. from 2020 to 2021, and the Chief Human Resources Officer at Certara, Inc. from 2021 to 2024.
Ms. Sherman's education history includes a graduate degree from Rutgers State University of New Jersey, an undergraduate degree from Lehigh University, and a graduate degree from the University of Delaware.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERTARA, INC.
0,02% | 01/04/2024 | 24 358 ( 0,02% ) | 412 868 $ | 31/05/2024 |
Postes actifs de Nicolette Sherman
| Sociétés | Poste | Début |
|---|---|---|
| Deirdres House | Président | - |
Anciens postes connus de Nicolette Sherman
| Sociétés | Poste | Fin |
|---|---|---|
| CERTARA, INC. | Responsable des Ressources Humaines | 21/05/2024 |
| OYSR POIN | Responsable des Ressources Humaines | 01/07/2021 |
| Sanofi Corp. | Corporate Officer/Principal | 01/04/2020 |
Formation de Nicolette Sherman
| Rutgers State University of New Jersey | Graduate Degree |
| Lehigh University | Undergraduate Degree |
| University of Delaware | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Entreprise privées | 3 |
|---|---|
| Sanofi Corp. | |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
| Deirdres House |
